Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C58726117-hydroxyprogesterone linoleic acid esterMeSH

  structure in first source

• C57835617-methoxyl-7-hydroxy-benzene-furanchalconeMeSH

  isolated from Millettia pulchra; structure in first source

• C56959117-oxo-5-androsten-3beta-yl 4-chlorobenzoateMeSH

  structure in first source

• C583337177Lu-DOTA-rituximabMeSH
• C56793917A non-coding RNA, humanMeSH

  regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease

• C58672617beta-hydroxy-16alpha-iodo-wortmanninMeSH

  structure in first source

• C58672817beta-hydroxy-16alpha-iodoPX866MeSH

  structure in first source

• Z3A.1818 weeks gestation of pregnancyICD-10-CM
• C56169118(R)-hydroxyeicosapentaenoic acidMeSH

  structure in first source

• C57192918,19-dihydroangustineMeSH

  from the leaves of Nauclea officinalis; structure in first source

• C57649718,21-diisopropyl-geldanamycin hydroquinoneMeSH

  structure in first source

• D01506918-HydroxycorticosteroneMeSH

  11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione.

• D01507018-HydroxydesoxycorticosteroneMeSH

  An analog of desoxycorticosterone which is substituted by a hydroxyl group at the C-18 position.

• C56818218-acetoxy-ent-kaur-16-eneMeSH

  analgesic and anti-inflammatory from Annona squamosa L. bark; structure in first source

• C57969818-formyloxy-8beta-hydroxysandaracopimar-15-eneMeSH

  from the leaves of Thuja orientalis; structure in first source

• C58768118-thiacrown-6MeSH

  structure in first source

• C582851188Re-MAG3-depreotideMeSH
• C569624188Re-MN-16ETMeSH

  has antineoplastic activity

• C57487318F-FBEM-Cys-Z(EGFR:1907) affibodyMeSH

  a PET probe for imaging tumors that overexpress epidermal growth factor receptor

• C57295518F-RGD-K5MeSH

  an alpha(v)beta(3) integrin marker; structure in first source

• C57417718F-ST889MeSH

  structure in first source

• Z3A.1919 weeks gestation of pregnancyICD-10-CM
• C57179019'-hexanoylfucoxanthinMeSH

  structure in first source

• C58753419(10-9)-abeo-8alpha,9beta,10alpha-tirucalla-5,25-diene-3beta,24-diolMeSH

  from Euphorbia mellifera; structure in first source

• C57160319,21-dimethyl triacont-17,22,24,26,28-pentaene-1-oic acidMeSH

  from the fruits of Lycium chinense; structure in first source

• C58286919-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)-4,5-dihydrogeldanamycinMeSH

  a natural geldanamycin analog from Streptomyces hygroscopicus 17997; structure in first source

• C58287019-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycinMeSH

  a natural geldanamycin analog from Streptomyces hygroscopicus 17997; structure in first source

• D01507119-IodocholesterolMeSH

  19-Iodocholest-5-en-3 beta-ol. A cholesterol derivative usually substituted with radioactive iodine in the 19 position. The compound is an adrenal cortex scanning agent used in the assessment of patients suspected of having Cushing's syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy.

• C56037319-S-methylgeldanamycinMeSH

  geldanamycin analog from Streptomyces hygroscopicus; structure in first source

• C57863719-hydroxypsammaplysin EMeSH

  antimalarial from the Balinese marine sponge Aplysinella strongylata; structure in first source

• C58397419-hydroxysarmentogeninMeSH

  from Crossopetalum gaumeri; structure in first source

• C56961819-nor-2-(3-hydroxypropyl)-1,25-dihydroxyvitamin D3MeSH

  has antineoplastic activity

• C5756691H-azepine-4-amino-4-carboxylic acidMeSH

  structure in first source

• C5695501H-benzimidazol-2-ylmethyl-N-phenylamineMeSH

  has antibacterial activity; structure in first source

• C5881191H-dibenzo(a,c)carbazoleMeSH

  structure in first source

• C5841881H-imidazo(4,5-h)(1,6)naphthyridin-2(3H)-oneMeSH

  structure in first source

• C5597771H-imidazol-4-ylacetic acidMeSH

  structure in first source

• C5872981H-indole-2-carboxylic acid (2-(3-(4-(1H-indol-3-yl)-1-methyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-indol-1-yl)-ethyl)-amideMeSH

  synthetic compound, structure in first source

• C5718871H-indole-3-carbaldehyde quinolin-8-yl-hydrazoneMeSH

  inhibits T-cell expansion

• C5827651H-indole-3-ethylene-5-nitrosalicylaldimineMeSH

  a gastroprotective agent; structure in first source

• C5811851H-pyrrolo(3,2-h)quinolineMeSH

  structure in first source

• C5822121NMPP1 compoundMeSH

  structure in first source

• C5723591R,2R-dicamphanoyl-3,3-dimethydihydropyrano(2,3-c)xanthen-7(1H)-oneMeSH

  structure in first source

• C5797321S-minwanenoneMeSH

  structure in first source

• C5735531a,3,5,5a-tetrahydro-1H-2,3-diazacyclopropa(a)pentalene-4-carboxylic acidMeSH

  a GPR109a agonist; structure in first source

• C5762551alpha,10beta-epoxy-4-hydroxy-glechoma-5-en-olideMeSH

  from Glechoma hederacea L.; structure in first source

• C5817261alpha,25-dihydroxy-9-methylene-10,19-dihydrovitamin D3MeSH

  structure in first source

• C5776751alpha,3-dipyrrolidino-androsta-3,5-diene-17-oneMeSH

  structure in first source

• C5857861alpha,3alpha-dihydroxy-5beta-pregn-16-en-20-one 3-O-alpha-L-rhamnopyranosideMeSH

  from Reineckia carnea herba; structure in first source

• C5703131alpha,3beta-dihydroxy-urs-12-en-11-one-3-yl palmitateMeSH

  from Sambucus adnata; structure in first source